Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Colitis, Ulcerative 4Inflammatory Bowel Diseases 3Crohn Disease 3Arthritis, Rheumatoid 3Graft vs Host Disease 2Cachexia 2Anorexia 2Recurrence 1Rare Diseases 1Psoriasis 1Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Kidney Transplantation 1Inflammation 1Hypertension 1Gastrointestinal Diseases 1Fatigue 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1Arthritis, Psoriatic 1Anemia 1

Interventions

Epoetin Alfa 43Darbepoetin alfa 33epoetin beta 10ferric carboxymaltose 6Cyclosporine 4Cisplatin 4ferrous sulfate 3Radiotherapy 3Lenalidomide 3peginesatide 2luspatercept 2hematide 2fludarabine 2ferric gluconate 2continuous erythropoietin receptor activator 2Therapeutics 2Filgrastim 2Erythropoietin 2Dexamethasone 2Cyclophosphamide 2Brachytherapy 2Antilymphocyte Serum 2ACE-011 2thymoglobulin 1ruxolitinib 1roxadustat 1reolysin 1pegfilgrastim 1obinutuzumab 1leridistim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia × Infliximab × Clear all
NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Centocor, Inc.

Phase 2 Completed
73 enrolled
Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡